Speakers

Speaker overview coming soon...

Rajesh Gupta is the Corporate VP – Dermatology Therapeutic Area at Merck-Serono International SA. During his career Rajesh has Global registration and launch of products in all Serono markets and was directly responsible for sales and operating expenses for. A career highlight would be as the owner of strategic alliance with Genentech on Raptiva. To date, Rajesh has built a business with Euro 93 million annual sales and a market share of 27%, He has degrees from University College, London, and the University of Brighton. Rajesh’s strengths are negotiating and detailed strategic account management as they relate to securing the close. Rajesh is also a credentialed master presenter.

Veronique Toully joined UCB in 2004 and subsequently headed up the group responsible for Global pricing reimbursement & access strategies.
In January 2009, Veronique was appointed to the position of Vice President of the newly created G3P group - Global Patients, Payers and Providers - within UCB.

Prior to joining UCB, Veronique had 10 years consulting experience in the area of pricing and reimbursement for drugs and medical devices, working for leading Fortune 500 pharmaceutical companies and biotechnology organizations. Veronique’s academic background is as a Doctor in Veterinary Medicine, she also has an MBA (HEC, Paris) and a Diploma in Health Economics from the University of York (UK).

Andreas Penk is Regional President Europe for the Pfizer Oncology Business Unit and Country Manager of Pfizer Germany. He has been Country Manager Pfizer Germany since March 2007.

Andreas joined Pfizer Germany in 1994 as Product Manager Hospital. In 1997 he was promoted to Head of the Strategic Business Unit Hospital and became Director of the Strategic Business Unit Hospital/CNS/Urology/Respiratory in 2000. From 2002 to 2007, Andreas was Country Manager of Pfizer Austria where he successfully completed the integration of Pharmacia.

Before joining Pfizer, Andreas served as a Project Manager in International Pharmaceutical Market Research at Infratest & GfK Pharmamarktforschung in Germany.

Andreas received his M.D. from Leipzig University School of Medicine in 1992.

Speaker overview coming soon...

Has more than 15 year experience in healthcare business gained in several international companies of various sizes and cultures (Baxter, Merck, Fournier, Solvay…). He has held a variety of positions in sales, operational marketing & strategic marketing..

Along his career, Eric has been serving and leading a lot of multidisciplinary projects and has developed special interest and expertise in the marketing input outside of the marketing field inc. drug development.

Eric has applied his experience to various therapeutic areas such as Renal Care, Urology, Oncology, Cardiovascular, Metabolic Disorders & Diabetes.

After having spent two years as VP of Business Portfolio & Strategy at Solvay Pharmaceuticals, he recently took a VP position in New Business Development as Head of Screening & Analytics.

Eric is French and graduated Paris University of Pharmacy as well as ESSEC Business School.

Speaker overview coming soon...

Richard Farquharson has worked in the Pharmaceuticals industry for over 20 years. He has experience across the commercial sector including domestic brand launch, global brand launch, US sales leadership, emerging compound strategy development and regional business management. He has worked domestically in the UK, Japan and the US and over his career has worked in the therapy areas of CV, Respiratory & Inflammation, Neuroscience, GI and Oncology.

Recently with AstraZeneca he led the Global Emerging Respiratory & Inflammation portfolio and ran the G& / Neuroscience primary care business in the North-East USA. For the past 3 years Richard has worked within the Global Marketing division of AstraZeneca as Director of New Marketing Practice. In this role Richard has been identifying, then developing innovative approaches that can be built into the Brand Design process to deliver world-leading brand strategies to the marketplace.

Richard is based in Cheshire, UK at one the AstraZeneca's Global Marketing sites.

Ahmed Afifi is an Emerging Growth Markets Brand Leader with Novartis oncology. His core strength lies in the development and implementation of regional marketing strategies for CML brands. He also oversee’s the effective creation and implementation of the local key marketing plans through the local marketing teams. Prior to this role Ahmed was the head of Novartis’s Oncology business unit in the Arabian Gulf region where Ahmed succeeded in leading, managing and developing the overall performance of the business units’ product portfolio. Ahmed studied pharmacy in the University of Cairo and hold MBA with major marketing from the AAM academy.

Jo Jarvis is Head of Advocacy for Wyeth Pharmaceuticals where she has worked since 1990. In this leadership position she has developed the role and enabled objective identification, selection and integration of therapeutic experts and stakeholders to support business objectives with established products, newly launched products and also future products to ensure maximization of brand impact. This has also included NICE/SMC stakeholder management plan development.

Speaker overview coming soon...

Speaker overview coming soon...

Speaker overview coming soon...

Speaker overview coming soon...

Dr.Carmen López-Lavid is graduated in Medicine and Surgery from the Autonomous University of Madrid and  is Specialist in Microbiology and Parasitology.

After seven years of clinical practice, she joined the Medical Department of Glaxo where she spent two years. She joined MSD Spain in 1994 being in charge of the Anti-infectives Unit for five years.

In 1999 she is promoted to Executive Manager of Outcomes Research (Health Economics) where she developed economic and humanistic studies and was member of the pricing and reimbursement committee. In 2002 she is promoted to Communication and Public Affairs Director and member of the Executive Management Committee.

She is currently in charge of Corporate Communication, Internal Communication, Product support communication, Corporate Social Responsibility and Patient Support Unit.

She has a master's degree in Health Management,Master in Marketing Direction and Master in Strategic Communication.

She is married and has three boys.

Royal School of Naval Warfare, Näsby Park, 1985
MSc Pharmacy, Uppsala University, 1987-1991
BSc Business Administration, Uppsala University, 1987-1991
Medical Representative, LEO Pharma Nordic, 1991-1994
Product Manager, LEO Pharma Nordic, 1994-2000
Sales manager, LEO Pharma Nordic, 2000-2005
Marketing Director, LEO Pharma Nordic, 2005-

Wolfgang is Senior Director of Sales Force at Nycomed in Germany. Following a Postdoc research fellowship in molecular biology and immunology he started his career in Pharmaceutical industry with ALTANA. Wolfgang has held several marketing and sales positions in different geographies. His leadership and management experience includes marketing and sales teams focussing on various primary and secondary care, NHS and Key Account customer as well. He has gathered experience for many brands in areas including Gastroenterology, Respiratory, Osteoporosis, Pain and Tissue Management.

Education:
General Engineering – Ecole Centrale Paris (France)

Job History:
2002 – 2005: WE Consumer Databases system manager – Procter & Gamble
2006 – 2007: IT Manager – Procter & Gamble Pharmaceuticals France and Belgium
2008 – now: IT Manager – Procter & Gamble – Pharmaceuticals & Oral Care Western Europe

Daan Vens, born in 1979 in Ghent (Belgium), has a master degree in International Politics and a postgraduate in multilingual business communication. Joining Janssen-Cilag in Belgium in 2003, he accumulated a big sales rep experience in neurology and psychiatry markets. Moving to France in 2006, after a short time on the field (which did pretty good to his French), he joined the IT department and is driving most of the CRM and E-business projects for Janssen-Cilag France.

Passionate about music, politics and especially travelling makes Paris a great hub to discover other countries and cultures on a professional and personal basis.

17 years experience in pharmaceutical industry.

Variety of positions in sales, customer/operational marketing and general management – ranging from sales rep to Managing Director – in Germany, The Netherlands, Benelux, and in P&G’s European Head Office in Geneva.

Special experience over the past years in developing new business models, including combination of OTC and Rx, use of digital sales platforms and organizational development.

Günther Illert, Vice President, is a member of Capgemini’s Global Life Sciences leadership team. During his 17 years in consulting, he gained deep experience in complex, international business transformations. His consulting focus is on pharma commercial operations. Prior to consulting, Günther Illert worked for several years in marketing and market research for a major international consumer goods company. Günther studied Business Administration in Passau and obtained his MBA from IMD in Lausanne. He is married and has three sons aged 12, 14 and 17 years.

Carwyn Jones is Head of Pharma at Doctors.net.uk, the largest andmost active network of medical professionals in the UK.

Doctors.net.uk has a membership comprising the vast majority of UK doctors. Each week over 50,000 use the service making it the online professional resource most frequently used by them. The network provides extensive clinical content including online education, conference highlights, user-generated content and discussion for a.

Doctors.net.uk provides a channel through which the health service and industry can effectively communicate with and research the opinions of medical professionals. 

The company’s charter states unequivocally what members can expect from Doctors.net.uk, especially with regard to editorial integrity, transparency and its relationship with public sector and commercial partners. These guidelines safeguard the network’s credibility, members’ privacy and ensure that engagement of the healthcare industry with doctors supports best practice and improved healthcare.

Carwyn has 15 years pharmaceutical experience in marketing, sales, and strategy with Eli Lilly, GSK and the healthcare agency sector.

Ed is a Principal with ZS Associates in Princeton, NJ and Lead for the Market Access and Pricing Practice.  He has extensive experience in pharmaceutical marketing and pricing from both the corporate pharma and consultancy perspective.

He has gained extensive experience in the pharmaceutical industry through various sales, marketing and general management positions for Lederle, Wyeth, Eli Lilly and BMS in the United States and Europe. 

Ed has gained deep expertise in Global Pricing and Reimbursement both on an affiliate level as a general manager of a European affiliate and at corporate head quarters as the responsible leader for global pricing and health economics groups in Wyeth, Eli Lilly and BMS. 

Prior to his recent leadership position at BMS, Ed has been Pricing and Reimbursement consulting practices in The Analytica Group, Cambridge Pharma consultancy and his own consultancy firm.  During this time he has advised many large drug companies on product pricing & market access strategy, global pricing policy and internal organizational and process challenges.  Most of these projects involved global payer and pricing research through a host of qualitative and quantitative methodologies. 

Ed has also served as an expert pricing consultant in a WHO/WTO sponsored dialog on differential pricing of drugs between governments, industry, consumer organizations and NGO’s.